C-Reactive Protein Testing Market Study Highlights How Industry Demand Is Evolving

The global market for C-reactive protein (CRP) testing is set for consistent expansion as healthcare technologies and diagnostic needs evolve. Increasing demand for rapid and precise inflammation detection, combined with advancements in automated platforms, is driving this sector forward. Let's explore the market's size, leading players, emerging trends, and key segments shaping its future.

Projected Growth and Market Size of the C-Reactive Protein Testing Market
The C-reactive protein testing market is forecasted to grow steadily, reaching a valuation of $4.48 billion by 2030. This expansion is expected to happen at a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth include a rising need for point-of-care testing for inflammatory conditions, wider adoption of automated diagnostic systems, expansion in preventive healthcare screenings, increased use of high-throughput laboratory technologies, and a growing emphasis on personalized diagnostic approaches. Key trends anticipated during the forecast period involve greater uptake of high-sensitivity CRP assays, more frequent use of automated immunoassay tools, heightened demand for quick inflammation diagnostics, increased application of CRP testing in cardiovascular risk evaluation, and ongoing efforts to enhance laboratory automation workflows.

Download a free sample of the c-reactive protein testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6719&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Leading Players Driving the C-Reactive Protein Testing Market
The market features a strong presence of several prominent companies that are instrumental in advancing CRP testing technologies and services. These include Thermo Fisher Scientific Inc., F Hoffmann-La Roche AG, Danaher Corporation, Quest Diagnostics Incorporated, Siemens AG, Abbott Laboratories, Aidian Oy, Boditech Med Inc., Horiba Ltd., Laboratory Corporation, Merck KGAA, Randox Laboratories Limited, Getein Biotech Inc., Bio-Rad Laboratories Inc., DiaSorin S.p.A., Eurofins Scientific SE, Inova Diagnostics Inc., Luminex Corporation, Sekisui Diagnostics LLC, Sysmex Corporation, Tosoh Corporation, Trinity Biotech Plc, WerfenLife Group LLC, ZEUS Scientific Inc., BioMérieux SA, Biomerica Inc., Gold Standard Diagnostics Corp., Immunodiagnostic Systems Holdings PLC, and Nova Biomedical Corporation.

Significant Acquisition Enhances Roche's CRP Testing Portfolio
In July 2024, Switzerland-based Roche strengthened its position in the CRP testing market by acquiring LumiraDx's point-of-care platform for an undisclosed sum. This strategic move allows Roche to integrate LumiraDx's rapid and quantitative CRP assay into its diagnostics offerings, broadening access to point-of-care immunoassays. LumiraDx, headquartered in the UK, specializes in multi-assay point-of-care platforms, including a microfluidic immunoassay designed for precise quantitative CRP testing.

View the full c-reactive protein testing market report:
https://www.thebusinessresearchcompany.com/report/c-reactive-protein-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Technological Innovations Shaping the C-Reactive Protein Testing Market
Companies in the CRP testing space are focused on advancing technologies, particularly high-sensitivity automated immunoassays that enable faster, more accurate, and low-level CRP detection. These improvements are crucial for early cardiovascular risk assessment and real-time inflammation monitoring. High-sensitivity automated immunoassays employ refined immunoturbidimetric or nephelometric methods to detect CRP levels well below what standard assays can measure, supporting earlier clinical intervention and better prognosis.

New Product Launch Demonstrating Innovation in CRP Detection
For example, in January 2024, Siemens Healthineers, a Germany-based in vitro diagnostics firm, introduced the Atellica CH High Sensitivity C-Reactive Protein 2 (hCRP2) assay for use with its Atellica CH Analyzer. The assay includes two ready-to-use reagents: one with phosphate buffer and surfactant, and the other containing monoclonal anti-CRP antibodies attached to polystyrene particles. When CRP in a patient's sample causes these particles to aggregate, the resulting light scattering is measured and correlates with CRP concentration. This system enables detection of very low CRP levels, supports cardiovascular risk stratification, works with serum or plasma samples, and provides rapid quantitative results to aid timely clinical decisions.

Main Segments Covered in the Global CRP Testing Market Analysis
The global CRP testing market is segmented into several key categories:
1) By Assay Type:
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Chemiluminescence Immunoassay (CLIA)
- Immunoturbidimetric Assays
2) By Application:
- Diabetes
- Rheumatoid Arthritis
- Cardiovascular Disease
- Inflammatory Bowel Disease
- Cancer
- Other Applications
3) By End Use:
- Clinics
- Hospitals
- Diagnostic Laboratories

Breaking down further, ELISA assays include direct ELISA, indirect ELISA, and sandwich ELISA types; CLIA assays are divided into luminometer-based and automated CLIA systems; immunoturbidimetric assays comprise nephelometry-based and latex agglutination immunoturbidimetric assays.

This detailed segmentation highlights the variety of testing technologies and clinical areas where CRP diagnostics play a vital role, reflecting the broad utility and evolving sophistication of this market.

Our 2026 market reports now feature expanded strategic intelligence through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, key technology and future trend analysis, along with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.